STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ZGNX ZOGENIX INCORPORATED StockScouter® Report

2

StockScouter® Score

ZOGENIX INCORPORATED, a small cap growth company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for ZGNX suggests strong price movement over the medium term. Positive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for ZGNX. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
F
F

Previous Ratings

2
4
5